Form 4: Longeveron Director Ursula Ungaro Awarded 17,000 Restricted Stock Units

Longeveron Inc. Director Ursula Ungaro was awarded 17,000 Class A Common Stock shares as time-based vesting Restricted Stock Units, increasing her beneficial ownership to 41,000 shares.

Summary

• Ursula Ungaro, a Director of Longeveron Inc. (LGVN), acquired 17,000 shares of Class A Common Stock on July 15, 2025.
• These shares were awarded as time-based vesting Restricted Stock Units (RSUs) at a price of $0 per share.
• Following this transaction, Ursula Ungaro's total beneficial ownership in Longeveron Inc. increased to 41,000 shares, which includes RSUs subject to future vesting.

Sentiment

Score: 7

Explanation: The award of equity to a director is generally a positive sign, indicating alignment of interests and commitment, though it's a routine compensation event rather than a major strategic announcement.

Positives

• An insider, Director Ursula Ungaro, received an award of 17,000 Restricted Stock Units, aligning her interests with shareholders.
• The increase in beneficial ownership to 41,000 shares demonstrates continued commitment from a director.

Risks

• The value of the Restricted Stock Units is subject to future vesting conditions and the market price of Longeveron Inc. Class A Common Stock.

Future Outlook

The award of Restricted Stock Units implies future vesting, aligning the director's long-term interests with the company's performance.

Management Comments

• The filing indicates that the award 'Represents the award of time-based vesting Restricted Stock Units (RSUs)' and 'Includes RSUs subject to future vesting'.

Industry Context

This type of equity award (RSUs) is a common form of executive and director compensation in the biotechnology and pharmaceutical industries, aiming to incentivize long-term performance and retention.

Comparison to Industry Standards

• Equity awards like RSUs are standard practice across publicly traded companies, particularly in growth-oriented sectors such as biotechnology.
• While specific compensation details vary, the use of time-based vesting RSUs is a common mechanism to align director incentives with shareholder value creation, similar to practices observed at comparable small-cap biotech firms.

Stakeholder Impact

• Shareholders: The award aligns the director's interests with shareholders through equity ownership.

Next Steps

• The awarded Restricted Stock Units are subject to future vesting conditions.

Key Dates

Recommendation

Keywords

Longeveron Inc., LGVN, Restricted Stock Units, RSU, Insider Ownership, Director Compensation, Equity Award, Form 4, Beneficial Ownership